Geisinger KR, Homesley HD, Morgan TM, et al. Endometrial adenocarcinoma: a multiparameter clinicopathologic analysis including the DNA profile and sex hormone receptors. Cancer 1986;58:1518– 1525.
163.
Palmer DC, Muir IM, Alexander AI, et al. The prognostic importance of steroid receptors in endometrial carcinoma.Obstet Gynecol 1988;72:388–393.
164.
Chambers JT, MacLusky N, Eisenfeld A, et al. Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer. Gynecol Oncol 1988;31:65–81.
165.
Ambros RA, Kurman RJ. Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. Gynecol Oncol 1992;45:235–239.
166.
Iverson OE. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 1986;155:770–776.
167.
Newbury R, Schuerch C, Goodspeed N, et al. DNA content as a prognostic factor in endometrial carcinoma. Obstet Gynecol 1990;76:251–257.
168.
Stendahl U, Strang P, Wegenius G, et al. Prognostic significance of proliferation in endometrial adenocarcinomas: a multivariate analysis of clinical and ﬂow cytometric variables. Int J Gynecol Pathol 1991;10:271–284.
169.
Ikeda M, Watanabe Y, Nanjoh T, et al. Evaluation of DNA ploidy in endometrial cancer. Gynecol Oncol 1993;50:25–29.
170.
Podratz KC, Wilson TO, Gaffey TA, et al. Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients. Am J Obstet Gynecol 1993;168:1206– 1213.
171.
Friberg LG, Noren H, Delle U. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study. Gynecol Oncol 1994;53:64–69.
172.
Susini T, Rapi S, Savino L, et al. Prognostic value of ﬂow cytometric deoxyribonucleic acid index in endometrial carcinoma: comparison with other clinical-pathologic parameters. Am J Obstet Gynecol 1994;170:527–534.
173.
Pisani AL, Barbuto DA, Chen D, et al. HER-2/neu, p53, and DNA analysis as prognosticators for survival in endometrial carcinoma. Obstet Gynecol 1995;85:729–734.
174.
Zaino RJ, Davis ATL, Ohlsson-Wilhelm BM, et al. DNA content is an independent prognostic indicator in endometrial adenocarcinoma. Int J Gynecol Pathol 1998;17:312–319.
175.